Atypical presentation of mitral valve pseudoaneurysm in a patient with obstructive hypertrophic cardiomyopathy complicated by endocarditis and severe pericardial effusion: A case report.
DOI:
https://doi.org/10.37615/retic.v8n1a12Keywords:
obstructive hypertrophic cardiomyopathy, infective endocarditis, pseudoaneurysm, vasculitisAbstract
Obstructive hypertrophic cardiomyopathy, owing to the turbulent flow it generates, is one of the predisposing factors for infective endocarditis. The morbidity and mortality associated with this condition necessitate prompt diagnosis and treatment, where echocardiography plays a pivotal role. Herein, we present a case of a patient with hy-pertrophic cardiomyopathy who develops mitral endocarditis secondary to a pseudo-aneurysm over the A2 scallop, complicated by vasculitis, severe pericardial effusion, and valvular destruction with severe mitral insufficiency requiring valvular replacement surgery.
Downloads
Metrics
References
Fernández-Hidalgo N, Tornos Mas P. Epidemiology of infective endocarditis in Spain in the last 20 years. Rev Esp Cardiol (Engl Ed). 2013 Sep;66(9):728-33. doi: https://doi.org/10.1016/j.rec.2013.05.002
Habib G, Erba PA, Lung B, et al. EURO-ENDO Investigators. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019 Oct 14;40(39):3222-3232. doi: https://doi.org/10.1093/eurheartj/ehz620
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016 Feb 27;387(10021):882-93. doi: https://doi.org/10.1016/S0140-6736(15)00067-7
Murdoch DR, Corey GR, Hoen B, et al. International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar 9;169(5):463-73. doi: https://doi.org/10.1001/archinternmed.2008.603
Delgado V, Ajmone Marsan N, de Waha S, et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14;44(39):3948-4042. doi: https://doi.org/10.1093/eurheartj/ehad193
Casabé J. H, Fernández A, Renedo MF, et al. Endocarditis infecciosa en la miocardiopatía hipertrófica. Rev. argent. cardiol. 2015 Ago;83(4): 335-338.
Servy A, Valeyrie-Allanore L, Alla F, et al. Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol. 2014;150(5):494-500. doi: https://doi.org/10.1001/jamadermatol.2013.8727
Tous-Romero F, Delgado-Márquez AM, Gargallo-Moneva V, et al. Cutaneous vasculitis: a presentation with endocarditis to keep in mind. An Bras Dermatol. 2017 Jul-Aug;92(4):594-595. doi: https://doi.org/10.1590/abd1806-4841.20176317
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Javier Mario Valcuende Rosique, Jorge Miguel Briceño Revillo, David Méndez Portuburu, Luis René Puglla-Sánchez, Jose Ramón Ruiz Arroyo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
